These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 33167571)

  • 21. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).
    Shah S; Das S; Jain A; Misra DP; Negi VS
    Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxychloroquine plus standard of care compared with standard of care alone in COVID-19: a meta-analysis of randomized controlled trials.
    Amani B; Khanijahani A; Amani B
    Sci Rep; 2021 Jun; 11(1):11974. PubMed ID: 34099745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review.
    Rodrigo C; Fernando SD; Rajapakse S
    Clin Microbiol Infect; 2020 Aug; 26(8):979-987. PubMed ID: 32470568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk versus Benefit of Using Hydroxychloroquine to Treat Patients with COVID-19.
    Zhanel GG; Zhanel MA; Boreskie KF; Lynch JP; Karlowsky JA
    Can J Infect Dis Med Microbiol; 2021; 2021():5942366. PubMed ID: 34557260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis.
    Elavarasi A; Prasad M; Seth T; Sahoo RK; Madan K; Nischal N; Soneja M; Sharma A; Maulik SK; Shalimar ; Garg P
    J Gen Intern Med; 2020 Nov; 35(11):3308-3314. PubMed ID: 32885373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease.
    Satlin MJ; Goyal P; Magleby R; Maldarelli GA; Pham K; Kondo M; Schenck EJ; Rennert H; Westblade LF; Choi JJ; Safford MM; Gulick RM
    PLoS One; 2020; 15(7):e0236778. PubMed ID: 32701969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic review and meta-analysis of efficacy and safety of hydroxychloroquine and chloroquine in the treatment of COVID-19.
    Mittal N; Mittal R; Gupta MC; Kaushal J; Chugh A; Khera D; Singh S
    J Family Med Prim Care; 2021 Jun; 10(6):2126-2139. PubMed ID: 34322403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy and safety of hydroxychloroquine (HCQ) in treatment of COVID19 -a systematic review and meta-analysis.
    Choudhuri AH; Duggal S; Ahuja B; Biswas PS
    Indian J Med Microbiol; 2021 Apr; 39(2):159-170. PubMed ID: 33781656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Meta-Analysis on the Effects of Hydroxychloroquine on COVID-19.
    Hussain N; Chung E; Heyl JJ; Hussain B; Oh MC; Pinon C; Boral S; Chun D; Babu B
    Cureus; 2020 Aug; 12(8):e10005. PubMed ID: 32983702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mortality, viral clearance, and other clinical outcomes of hydroxychloroquine in COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials.
    Kashour Z; Kashour T; Gerberi D; Tleyjeh IM
    Clin Transl Sci; 2021 May; 14(3):1101-1112. PubMed ID: 33606894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Updated Systematic Review of the Therapeutic Role of Hydroxychloroquine in Coronavirus Disease-19 (COVID-19).
    Das S; Bhowmick S; Tiwari S; Sen S
    Clin Drug Investig; 2020 Jul; 40(7):591-601. PubMed ID: 32468425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroxychloroquine in the treatment of coronavirus disease 2019: Rapid updated systematic review and meta-analysis.
    Gupta T; Thakkar P; Kalra B; Kannan S
    Rev Med Virol; 2022 Mar; 32(2):e2276. PubMed ID: 34245622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydroxychloroquine and mortality in COVID-19 patients: a systematic review and a meta-analysis of observational studies and randomized controlled trials.
    Di Castelnuovo A; Costanzo S; Cassone A; Cauda R; De Gaetano G; Iacoviello L
    Pathog Glob Health; 2021; 115(7-8):456-466. PubMed ID: 34128772
    [No Abstract]   [Full Text] [Related]  

  • 34. Treating COVID-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind Randomized Controlled Trial in Hospitalized Patients.
    Ulrich RJ; Troxel AB; Carmody E; Eapen J; Bäcker M; DeHovitz JA; Prasad PJ; Li Y; Delgado C; Jrada M; Robbins GA; Henderson B; Hrycko A; Delpachitra D; Raabe V; Austrian JS; Dubrovskaya Y; Mulligan MJ
    Open Forum Infect Dis; 2020 Oct; 7(10):ofaa446. PubMed ID: 33134417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19.
    García-Albéniz X; Del Amo J; Polo R; Morales-Asencio JM; Hernán MA
    Eur J Epidemiol; 2022 Aug; 37(8):789-796. PubMed ID: 35943669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis.
    Chivese T; Musa OAH; Hindy G; Al-Wattary N; Badran S; Soliman N; Aboughalia ATM; Matizanadzo JT; Emara MM; Thalib L; Doi SAR
    Travel Med Infect Dis; 2021; 43():102135. PubMed ID: 34265436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19.
    Ho TC; Wang YH; Chen YL; Tsai WC; Lee CH; Chuang KP; Chen YA; Yuan CH; Ho SY; Yang MH; Tyan YC
    Pathogens; 2021 Feb; 10(2):. PubMed ID: 33671315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colchicine for the treatment of COVID-19.
    Mikolajewska A; Fischer AL; Piechotta V; Mueller A; Metzendorf MI; Becker M; Dorando E; Pacheco RL; Martimbianco ALC; Riera R; Skoetz N; Stegemann M
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD015045. PubMed ID: 34658014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroxychloroquine (HCQ) Treatment for Hospitalized Patients with COVID- 19.
    Tsanovska H; Simova I; Genov V; Kundurzhiev T; Krasnaliev J; Kornovski V; Dimitrov N; Vekov T
    Infect Disord Drug Targets; 2022; 22(6):e030322201650. PubMed ID: 35240966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada.
    Wright JK; Tan DHS; Walmsley SL; Hulme J; O'Connor E; Snider C; Cheng I; Chan AK; Borgundvaag B; McLeod S; Gollob MH; Clarke RJ; Dresser L; Haji F; Mazzulli T; Mubareka S; Jüni P; Lee D; Tomlinson G; Kain KC; Landes M
    Trials; 2020 Jul; 21(1):647. PubMed ID: 32665039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.